DIRECCIÓN
LIVE STREAMING Ver mapaScientific Coordinators / Coordinadoras Científicas
- Dra. Enriqueta Felip
Hospital Universitari Vall d’Hebron. Barcelona. - Dra. Noemí Reguart
Hospital Clinic. Barcelona.
Programa
16:00h – 16:05h Bienvenida
-Dra. Enriqueta Felip, Hospital Universitari Vall d’Hebron, Barcelona
-Dra. Noemi Reguart, Hospital Clínic, Barcelona
16:05h – 18:00h SESSION I
Therapeutic innovation in advanced lung cancer
Chairs:
Dr. Mariano Provencio, Hospital Puerta de Hierro-Majadahonda, Universidad Autónoma de Madrid
Dr. Margarita Majem, Hospital de la Santa Creu i Sant Pau, Barcelona
16:05h – 16:30h Keynote lecture
Bridging gaps in advanced non-small cell lung cancer through next-generation immunotherapy
Prof. Solange Peters, Lausanne University Hospital, Switzerland
16:30h – 16:45h Small cell lung cancer in transition: re-engaging immunity and beyond
Dr. Luis Paz-Ares, Hospital Universitario 12 de Octubre, Madrid
16:45h – 17:00h Positioning ADCs in lung cancer (without AGAs): right target, setting, and timing
Dr. Jordi Remon, Hospital Gustave Roussy, Villejuif, France
17:00h – 17:15h The role of pathology in an evolving therapeutic landscape
Dr. Esther Conde, Hospital Universitario 12 de Octubre, Madrid
17:15h – 18:00h Debate
MESA II: Avances en el abordaje de dianas oncogénicas
Moderadores:
Dr. Joaquin Bosch, Institut Català d’Oncologia, Hospital Universitario Doctor Josep Trueta, Girona
Dr. Enric Carcereny, Institut Català d’Oncologia, Hospital Universitario Germans Trias i Pujol, Badalona
18:00h – 18:15h EGFR
Dr. Javier Castro, Hospital Universitario La Paz, Madrid
18:15h – 18:30h Inhibidores de KRAS
Dr. Ernest Nadal, Institut Català d’Oncologia, L’Hospitalet de Llobregat
18:30h – 18:45h Fusiones génicas
Dr. Rosario García Campelo, Complexo Hospitalario Universitario de A Coruña, La Coruña
18:45h – 19:00h BRAF, HER2, METex14
Dr. Edurne Arriola, Hospital del Mar, Barcelona
19:00h – 19:15h Debate
Conclusiones y cierre